Analysts Anticipate U.S. Physical Therapy, Inc. (NYSE:USPH) Will Announce Earnings of $0.51 Per Share

Wall Street brokerages expect that U.S. Physical Therapy, Inc. (NYSE:USPH) will post earnings per share…

Wall Street brokerages expect that U.S. Physical Therapy, Inc. (NYSE:USPH) will post earnings per share of $0.51 for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for U.S. Physical Therapy’s earnings. The highest EPS estimate is $0.67 and the lowest is $0.40. U.S. Physical Therapy reported earnings per share of $0.71 in the same quarter last year, which suggests a negative year over year growth rate of 28.2%. The business is expected to issue its next quarterly earnings results on Thursday, November 5th.

On average, analysts expect that U.S. Physical Therapy will report full-year earnings of $1.82 per share for the current year, with EPS estimates ranging from $1.58 to $2.15. For the next year, analysts forecast that the company will report earnings of $2.66 per share, with EPS estimates ranging from $2.52 to $2.87. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for U.S. Physical Therapy.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.85 EPS for the quarter, topping the Zacks’ consensus estimate of ($0.18) by $1.03. U.S. Physical Therapy had a return on equity of 13.36% and a net margin of 6.64%. The firm had revenue of $83.86 million during the quarter, compared to analyst estimates of $87.24 million. During the same period last year, the company posted $0.81 EPS. The business’s quarterly revenue was down 33.6% compared to the same quarter last year.

Several analysts recently commented on USPH shares. ValuEngine lowered U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Tuesday, September 1st. Barrington Research increased their target price on U.S. Physical Therapy from $95.00 to $100.00 and gave the stock an “outperform” rating in a research note on Friday, August 7th. Finally, Zacks Investment Research raised U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $100.00 price objective on the stock in a report on Saturday, August 8th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $93.33.

Shares of NYSE USPH opened at $86.55 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.13. The business’s 50 day moving average is $88.82 and its two-hundred day moving average is $78.45. The company has a market cap of $1.11 billion, a P/E ratio of 36.06, a P/E/G ratio of 4.17 and a beta of 1.22. U.S. Physical Therapy has a 12 month low of $45.13 and a 12 month high of $148.48.

In related news, CFO Lawrance W. Mcafee sold 4,450 shares of the company’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $91.41, for a total transaction of $406,774.50. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, COO Graham D. Reeve sold 1,500 shares of the business’s stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $90.21, for a total transaction of $135,315.00. The disclosure for this sale can be found here. 2.00% of the stock is owned by company insiders.

Large investors have recently added to or reduced their stakes in the company. Two Sigma Advisers LP purchased a new stake in U.S. Physical Therapy during the second quarter worth $1,199,000. Nuveen Asset Management LLC grew its holdings in shares of U.S. Physical Therapy by 0.4% in the second quarter. Nuveen Asset Management LLC now owns 56,816 shares of the company’s stock valued at $4,603,000 after purchasing an additional 254 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in U.S. Physical Therapy by 8.8% in the second quarter. Charles Schwab Investment Management Inc. now owns 85,811 shares of the company’s stock worth $6,953,000 after acquiring an additional 6,946 shares during the last quarter. Engineers Gate Manager LP lifted its stake in U.S. Physical Therapy by 153.2% in the second quarter. Engineers Gate Manager LP now owns 11,053 shares of the company’s stock worth $896,000 after acquiring an additional 6,687 shares during the last quarter. Finally, California State Teachers Retirement System lifted its position in shares of U.S. Physical Therapy by 1.6% during the 2nd quarter. California State Teachers Retirement System now owns 19,278 shares of the company’s stock worth $1,562,000 after buying an additional 296 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Article: What are the benefits of a portfolio tracker?

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy and related companies with MarketBeat.com’s FREE daily email newsletter.